Votes & Verdicts cover art

All Episodes

Votes & Verdicts — 149 episodes

#
Title
1

Why Mortgage Rates Are Stuck Above 6%

2

Proposed Ban on Institutional Home Ownership

3

Iran, Musk v. OpenAI, Live Nation, Visa, Pot

4

Treyz on Trump, Iran, Fed, Midterms, Tariffs

5

Trump’s Influence on Energy, Gasoline Prices

6

Ret. Col. Wayne Sanders on the Iran War

7

Betting on Prediction Markets — Path Ahead

8

Cato’s Skorup on Risks to Broadcast Licenses

9

Bank Rules, Anthropic, Sable, DOJ v. Powell

10

Sayyed on the State of Antitrust Enforcement

11

Bayer, Abbott, J&J Billion-Dollar Tort Risk

12

SCOTUS Tariff-Ruling Aftermath With Ted Murphy

13

Joyce Adetutu on SCOTUS IEEPA Tariff Ruling

14

Live Nation Antitrust, Kalshi, Nexstar-Tegna

15

Coinbase CLO Grewal on Crypto, Event Contracts

16

Ted Murphy on SCOTUS IEEPA Tariff Ruling

17

Orsted, Equinor, Peers in Offshore Headwinds

18

Credit Card Caps, FCC Fines, Powell Probe

19

NJ AG Platkin on AI, CFPB, Kalshi, Trump

20

Legal, Policy Catalysts for Investors 2026

21

Netflix/Paramount Antitrust, AI EO, Farm Aid

22

Warner Bros. Bids, Zillow, Bayer in SCOTUS

23

Meta Win, Trump’s AI Order, Epstein/JPMorgan

24

ACA Future, CFPB Funds, Visa/Mastercard Pact

25

Tariffs in SCOTUS; Pfizer v. Novo, Metsera

26

Trump in Asia, SNAP, H-1Bs, Apple Antitrust

27

IPOs, Trump v. NYT, FTC v. PBMs, BNP Paribas

28

Shutdown, Crypto, Fannie-Freddie, Musk’s Pay

29

Shutdown, H-1B Visas, Google, Abbott/Reckitt

30

Zillow Antitrust, TikTok, Tariffs, Shutdown

31

H-1B Fees, Anthropic, Shutdown Odds, Kenvue

32

Shutdown, Kimmel, Trump/NYT, FTC/LiveNation

33

Tariff Regulatory Risk? Ask a Trade Lawyer

34

Google Ruling, Tariffs/SCOTUS, Cook v. Trump

35

Cook v. Trump, Nexstar/Tegna, Govt. Shutdown

36

BI’s Larry Tabb on SEC’s Project Crypto

37

Trump on Fannie-Freddie, 401(k)s and Powell

38

Trump M&A, PBMs, Tariffs, FCC Broadcast Regs

39

Tariffs Legality, DC Shutdown, Dick’s M&A

40

Robinhood’s Gallagher on Tokenization, Crypto

41

Legality of Trump’s Tariffs With Professor Yoo

42

Bank Deregulation, Tariff Rulings Among 2H Catalysts

43

Tax Bill’s Impact on Solar, Health Care, AI

44

AI Copyright Rulings, Trump Antitrust, PBMs

45

‘L Day’ Tariff Legality, With Stanford’s Sykes

46

GENIUS Act, Texas v. BlackRock, DOJ v. Visa

47

Wells Fargo, Fed, DOJ v. Google, TikTok Ban

48

Tariff Rulings, Fannie-Freddie, FTC v. Pepsi

49

Tax Bill, Spectrum Auctions, Fannie-Freddie

50

Berman on Antitrust: View from Plaintiff Bar

51

IRA, Drug Pricing, Tech Antitrust, EchoStar: Votes and Verdicts

52

Tariff Suits, Broadcast Caps, Crypto Bills

53

Trump’s First 100 Days, Trade, Taxes and More

54

Tariff Suits, Tech Antitrust and Tax Bill

55

Meta Trial, Google Hearing, House Tax Vote

56

Trump’s Liberation Day: A Trade Lawyer’s Take: Votes & Verdicts

57

Are Trump’s Tariffs Legal? TikTok Ban Update

58

Trump SEC, Tariffs, FTC Firings, FCC Subsidy

59

Broadcasters Take Shot at FCC Media Limits

60

OpenAI, Meta Fair Use Bids Risky in Copyright Drama

61

Abbott, Apple, Citi, Nexstar, Musk, OpenAI

62

Ex-FBI Chief of Staff on Risks to Business

63

Arizona AG Mayes on Antitrust, PFAS and More

64

PFAS Could Make a Comeback Under Trump EPA

65

Washington Predictions — Tariffs, Tax, Trump

66

O’Rielly on the FCC’s Regulation Under Trump

67

TikTok Countdown After Supreme Court Showdown

68

Trump, TikTok, US Steel Among 2025 Catalysts

69

Abbott-Reckitt Multibillion-Dollar NEC Suits

70

Arm, Bayer, Google, Kroger, Novo, TikTok

71

Is the TMT Playbook About to Be Rewritten Under Trump?

72

Antitrust Under Trump – Post-Election View

73

Trump’s Win and Its Industry Impacts

74

Harris, Trump and Election Effects on Energy

75

Harris, Trump Election Impact on Antitrust

76

Harris, Trump Election Impact on Consumer

77

Harris, Trump Election Impact on Industrials

78

Harris, Trump Election Effect on Health-Care

79

Nixon Peabody Trust Company's Kern on Elections, Global Markets

80

Tax Implications of the 2024 US Election

81

BI Analysts Discuss US Election Impact on TMT

82

BI Strategists on the 2024 US Elections and Their Market Impact

83

Harris, Trump Election Effects on Financials

84

TikTok-Ban Risk Soars After Key Court Hearing

85

Bayer, Abbott Billion-Dollar Mass-Tort Risk

86

Anthony Scaramucci on Trump v. Harris

87

Coinbase, Google, TikTok and Other Catalysts

88

Medicare’s First Negotiated Price List Is Here

89

Forever Chemicals, the Forever Litigation?

90

Alphabet, Amazon, Apple and Meta Antitrust Showdown Status

91

Artificial Intelligence’s Antitrust Concerns

92

US Elections, GSK, Kroger and More Catalysts: Votes and Verdicts

93

Robinhood's Gallagher, BI's Tabb on Gensler's SEC

94

Joe Grogan’s Outlook for Health-Care Policy

95

Chevron Doctrine’s Demise and Industry Risk

96

US Elections, Google, Basel III Are 2H Keys

97

Lyft, Uber and the California Prop. 22 Brief

98

Kraninger on Bank Regulations, CFPB, Crypto

99

Net Neutrality Gets Another Day in Court

100

Calabria on Fannie, Freddie Conservatorships

101

Catalysts for Apple, Alphabet, GSK, and Visa

102

Todd Phillips on Basel III, Chevron, Crypto

103

Durbin on Credit Cards, Airline Programs

104

Medicare’s Hospital-at-Home and Other Reforms

105

Is TikTok on the Countdown to a Shutdown?

106

Google, LiveNation, Uber and Other Catalysts

107

Kelleher on FinReg, ‘Kangaroo’ Courts

108

Pharma and Biotech Drug Pricing Policy Outlook

109

Antitrust Enforcers’ New Merger Guidelines

110

Eugene Scalia on Beating Regulators in Court

111

Market and Reimbursement Outlook for Cell and Gene Therapies

112

3M, Synopsys, Capital One & Other Catalysts

113

Can Legal State Pot Put US Law Up in Smoke?

114

Biden’s Lab-Developed Test Proposal

115

Biden’s Drug-Pricing Expansion Plan, Part 2

116

Apple, Bayer, Moderna and Other Catalysts

117

Apple’s Antitrust App-Store Battle With Epic

118

Washington’s Crowded Outlook for 2024

119

Biden’s Drug Pricing March-in Proposal

120

Meta’s Biggest Legal, Regulatory Questions

121

Antitrust Changes Could Hinder M&A

122

Apple, Disney, Novo Nordisk, Other Catalysts

123

J&J, 3M's Chap 11 Play in Talc, Earplug Mass Torts

124

Berkshire, Google, Pega & Other Catalysts

125

Consumer Finance Impact of a CFPB Run Amok

126

Will IRA Drug Pricing Raise Employer Costs?

127

JJCI, Bayer, GSK, Mass Tort Litigation Risks

128

Bausch, GBTC, Merck, Meta & Other Catalysts

129

AI’s Biggest Legal and Regulatory Questions

130

FTC BioPharma M&A Approach Clashes With Sector

131

Likelihood Medicare Will Cover Obesity Drugs

132

3M, Drug Pricing, Google and Other Catalysts

133

Can Anyone Defeat Trump? Insights on the Forthcoming GOP Debates

134

3M, Google, Bank Rules, Other 2H Catalysts

135

Craig Burton on Inflation Reduction Act

136

Why PFAS Legal Risks Persist for 3M, Peers

137

Why a TikTok Ban Faces a Major Legal Hurdle

138

Catalysts to Watch – AI Laws, PFAS Trial

139

Adamantine’s Bays on Sustainable Investing

140

Margaux Hall on Drug Pricing Negotiation

141

Bill Hoagland on Debt-Ceiling Negotiations

142

Daniel Horwitz on Trump Indictment Strengths

143

Gottlieb on the Future of Crypto Policy, Law

144

The PFAS Problem, Regulatory and Other Issues

145

Crisis of Confidence, Regional Banks’ Future

146

The FTC’s Evolving Approach to Assessing M&A

147

The Biggest Tech-Regulation Questions

148

Energy's DC Opportunity, Risk with Schneider

149

Mulvaney on Crypto, the CFPB, and More